Literature DB >> 15365907

Excitotoxic and post-ischemic neurodegeneration: Involvement of transglutaminases.

D Caccamo1, A Campisi, M Currò, G Li Volti, A Vanella, R Ientile.   

Abstract

Neurodegeneration induced by excitotoxicity is a common feature in various neurological disorders. This pathological condition is caused by prolonged stimulation of glutamate receptor subtypes, followed by both intracellular Ca2+ overload and activation of specific genes, resulting in synthesis of enzymes involved in cell stress response. Using experimental in vitro models of excitotoxicity, we demonstrated that glutamate exposure up-regulated tissue transglutaminase in primary cultures of both cerebellar granule cells and astrocytes. These changes were consequent to receptor-mediated Ca2+ influx, as demonstrated by the inhibition with selective antagonists, MK-801 and GYKI 52466. Early increases in different transglutaminase isoforms were also observed in global cerebral ischemia, which closely resembles neuronal damage caused by NMDA receptor activation. These findings agree with a postulated role for transglutaminases in molecular mechanisms of several neurodegenerative diseases. Indeed, increased cross-linking reactions could be of pathologic relevance, as part of biochemical changes observed in neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15365907     DOI: 10.1007/s00726-004-0117-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  15 in total

Review 1.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

2.  Diabetic human adipose tissue-derived mesenchymal stem cells fail to differentiate in functional adipocytes.

Authors:  Ignazio Barbagallo; Giovanni Li Volti; Fabio Galvano; Guido Tettamanti; Francesca R Pluchinotta; Sonia Bergante; Luca Vanella
Journal:  Exp Biol Med (Maywood)       Date:  2016-01-01

3.  Edaravone protects PC12 cells from ischemic-like injury via attenuating the damage to mitochondria.

Authors:  Ying Song; Meng Li; Ji-cheng Li; Er-qing Wei
Journal:  J Zhejiang Univ Sci B       Date:  2006-09       Impact factor: 3.066

Review 4.  The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.

Authors:  Seyed Soheil Saeedi Saravi; Seyed Sobhan Saeedi Saravi; Alireza Arefidoust; Ahmad Reza Dehpour
Journal:  Metab Brain Dis       Date:  2017-06-03       Impact factor: 3.584

5.  Pituitary adenylate cyclase-activating polypeptide type 1 receptor (PAC1) gene is suppressed by transglutaminase 2 activation.

Authors:  Ayako Miura; Yuki Kambe; Kazuhiko Inoue; Hideki Tatsukawa; Takashi Kurihara; Martin Griffin; Soichi Kojima; Atsuro Miyata
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

6.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

8.  Neuroprotective role of Bacopa monnieri extract in epilepsy and effect of glucose supplementation during hypoxia: glutamate receptor gene expression.

Authors:  C S Paulose; Finla Chathu; S Reas Khan; Amee Krishnakumar
Journal:  Neurochem Res       Date:  2007-10-18       Impact factor: 3.996

9.  Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.

Authors:  Gozde Colak; Jeffrey W Keillor; Gail V W Johnson
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

10.  Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons.

Authors:  Dirk Taubert; Gundula Grimberg; Werner Stenzel; Edgar Schömig
Journal:  PLoS One       Date:  2007-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.